Biosystems in Medical Products
Navigation Links
Biosystems in Medical Products
Applied Biosystems 3730 DNA Analyzer
Description: The 48-capillary 3730 DNA Analyzer, upgradeable to 96 capillaries, is the ideal platform for high-throughput DNA analysis. Higher optical sensitivity and advanced polymers enable you to obtain higher-quality data at a lower cost. Multiple automation features decrease costly human errors. ...Company:Applied Biosystems
Applied Biosystems 3730xl DNA Analyzer
Description: The 96-capillary 3730xl DNA Analyzer reduces the time, cost, and complexity of large-scale projects. Higher optical sensitivity and advanced polymers enable you to obtain higher-quality sequencing data for less. Multiple automation features decrease costly human errors. Optimized polym...Company:Applied Biosystems
Applied Biosystems 9800 Fast Thermal Cycler
Description: The Applied Biosystems 9800 Fast Thermal Cycler is an integral component of the Applied Biosystems 9800 Fast PCR System, which reduces PCR reaction time from 2 hours to as little as 25 minutes -- moving your research forward quicker than ever before....Company:Applied Biosystems
Applied Biosystems 2720 Thermal Cycler
Description: This personal-sized Thermal Cycler is the ideal instrument for budget-conscious labs that want to perform a full range of PCR applications. Get Applied Biosystems proven PCR performance at an affordable price. Save lab space without sacrificing results. Enhance productivity with intuitive sof...Company:Applied Biosystems
Applied Biosystems 7300 Real-Time PCR System
Description: The Applied Biosystems 7300 Real-Time PCR System gives you advanced, multicolor real-time PCR capabilities with exceptional budget sensitivity. Four-color detection enables you to perform gene expression analysis, pathogen quantitation, SNP genotyping, and plus/minus assays with internal po...Company:Applied Biosystems
Applied Biosystems 7500 Real-Time PCR System
Description: The Applied Biosystems 7500 Real-Time PCR System is a versatile, leading edge platform offering enhanced performance capabilities and a future upgrade to high speed thermal cycling. Variable excitation and five-color detection enable you to use a broad range of fluorophores including FAM/SYBR Gre...Company:Applied Biosystems
Agarose for the Separation of GeneAmp® PCR Products
Description:... A custom blend for Applied biosystems by FMC. Designed specifically for the electrophoresis of PCR products....Company:Applied Biosystems
ABI PRISM® 3100-Avant Genetic Analyzer
Description:... In 2000, Applied biosystems introduced the completely automated, 16-capillary ABI PR I S M 3100 Genetic Analyzer. Now the innovative technology of the 3100 instrument is availa...Company:Applied Biosystems
Description:... Applied biosystems has designed its 60-well, 0.5 mL GeneAmp PCR System 9700 specifically for high-sample-volume PCR applications (both DNA and RNA). The heated lid and u...
Company:Applied Biosystems
ABI PRISM Optical Adhesive Cover Starter Kit
Description:... Applied biosystems has developed a comprehensive set of guidelines to ensure success when using sequence detection systems (SDS) reagents and instrumentation. These guid...Company:Applied Biosystems
ABI PRISM Optical Adhesive Covers
Description:... Applied biosystems has developed a comprehensive set of guidelines to ensure success when using sequence detection systems (SDS) reagents and instrumentation. These guid...Company:Applied Biosystems
ViroSeq HIV-1 Genotyping System
Description:...gimen for a particular patient. The product includes reagents for identifying key mutations of the HIV-1 genome and is designed for use on an Applied biosystems automated DNA sequencing instrument in conjunction with Celera Diagnostics' ViroSeq HIV-1 Genotyping System Software....Company:Celera Diagnostics
Other TagsisomerHEXHEXcarboxycarboxyABINABINABINABINOther Contentsfoodsfoodsfoodsfoodsfoodsfoodsforeskinforeskinfungalfungalfungalfungalfungalfungalfungalfragilefragilefragilefragilefragilefrostbite
pSMARTisomerHEXhexachlorofluoresceincarboxyMAGPJunctophilinFibulinTGFUCP1ABINsuccinimidylaminohexanoicDinitrophenyl
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Consumer Reports Health News August 2009 55382 1Consumer Reports Health News August 2009 55382 2Consumer Reports Health News August 2009 55382 3Consumer Reports Health News August 2009 55382 4Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 1Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 1Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 3Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 4(Date:12/5/2009)NEW ORLEANS, Dec. 5 There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in orde
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2[0] New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders[0] AVIVA's Private Health Insurance Products Solutions Go International[0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share[0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |